ATLANTA, Sept. 19, 2017 (GLOBE NEWSWIRE) -- Alimera Sciences, Inc. (Nasdaq:ALIM) (Alimera), a leader in the commercialization
and development of prescription ophthalmic pharmaceuticals, today announced that Dan Myers, CEO, will present at the Sidoti &
Company Fall 2017 Conference at the New York Marriott Marquis in New York, New York. Alimera Sciences’ presentation will take place
Thursday, September 28th at 9:05AM Eastern Time.
A live broadcast of the conference presentation will be available. To access the broadcast, go to the "Investor Relations"
section of the Company's website at www.alimerasciences.com. A replay of the conference presentation will also be available.
About Alimera Sciences, Inc.
www.alimerasciences.com
Alimera, founded in June 2003, is a pharmaceutical company that specializes in the commercialization and development of
prescription ophthalmic pharmaceuticals. Alimera is presently focused on diseases affecting the back of the eye, or retina, because
these diseases are not well treated with current therapies and will affect millions of people in our aging populations. Alimera’s
commitment to retina specialists and their patients is manifest in Alimera’s product and development portfolio designed to treat
early- and late-stage diseases. For more information, please visit www.alimerasciences.com.
